CRISPR Therapeutics (CRSP)
51.83
-5.12 (8.99%)
Upcoming Events
Latest Headlines
Form S-8 CRISPR Therapeutics AG
June 5, 2026 8:15 AM - SEC Filing
Form 8-K CRISPR Therapeutics AG For: Jun 04
June 4, 2026 4:45 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: May 29 Filed by: KASINGER JAMES R.
June 2, 2026 5:42 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: May 29 Filed by: Patel Naimish
June 2, 2026 5:42 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: May 29 Filed by: Prasad Raju
June 2, 2026 5:41 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: May 28 Filed by: Patel Naimish
June 1, 2026 5:36 PM - SEC Filing
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
May 28, 2026 8:00 AM - Globe NewsWire
CRISPR Therapeutics (CRSP) Reiterated at Market Outperform by Citizens
May 27, 2026 5:45 AM - StreetInsider
Form SCHEDULE 13G/A CRISPR Therapeutics AG Filed by: ORBIS INVESTMENT MANAGEMENT LTD
May 15, 2026 12:59 PM - SEC Filing
Form SCHEDULE 13G CRISPR Therapeutics AG Filed by: Capital World Investors
May 14, 2026 1:56 PM - SEC Filing
CRISPR Therapeutics (CRSP) PT Raised to $56 at Bernstein SocGen Group
May 13, 2026 7:15 AM - StreetInsider
Intellia short interest rises most among biotech stocks in latest period - Baird
May 12, 2026 9:58 AM - StreetInsider
CRISPR Therapeutics to Present at the Bank of America Securities 2026 Global Healthcare Conference
May 6, 2026 8:30 AM - Globe NewsWire
CRISPR Therapeutics (CRSP) PT Lowered to $98 at Jefferies
May 5, 2026 7:39 AM - StreetInsider
CRISPR Therapeutics (CRSP) PT Lowered to $83 at BofA Securities
May 5, 2026 5:12 AM - StreetInsider
Form 10-Q CRISPR Therapeutics AG For: Mar 31
May 4, 2026 4:49 PM - SEC Filing
Form 8-K CRISPR Therapeutics AG For: May 04
May 4, 2026 4:42 PM - SEC Filing
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results
May 4, 2026 4:30 PM - Globe NewsWire
Form SCHEDULE 13G/A CRISPR Therapeutics AG Filed by: ARK Investment Management LLC
April 30, 2026 12:41 PM - SEC Filing
Form ARS CRISPR Therapeutics AG For: Dec 31
April 21, 2026 8:18 AM - SEC Filing
Form DEFA14A CRISPR Therapeutics AG
April 21, 2026 8:11 AM - SEC Filing
Form DEF 14A CRISPR Therapeutics AG For: Jun 04
April 21, 2026 8:07 AM - SEC Filing
CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
April 7, 2026 12:29 PM - Globe NewsWire
Form PRE 14A CRISPR Therapeutics AG For: Jun 04
April 2, 2026 4:24 PM - SEC Filing
Legendary Investors are Rotating Capital into AI Powered Biotech
March 30, 2026 9:15 AM - StreetInsider
Form 4 CRISPR Therapeutics AG For: Mar 20 Filed by: KASINGER JAMES R.
March 24, 2026 5:38 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: Mar 20 Filed by: Kulkarni Samarth
March 24, 2026 5:38 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: Mar 20 Filed by: Prasad Raju
March 24, 2026 5:37 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: Mar 20 Filed by: Patel Naimish
March 24, 2026 5:37 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: Mar 14 Filed by: Patel Naimish
March 17, 2026 5:38 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: Mar 14 Filed by: Prasad Raju
March 17, 2026 5:37 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: Mar 14 Filed by: KASINGER JAMES R.
March 17, 2026 5:36 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: Mar 14 Filed by: Kulkarni Samarth
March 17, 2026 5:35 PM - SEC Filing
CRISPR Therapeutics (CRSP) PT Raised to $110 at Piper Sandler
March 17, 2026 7:12 AM - StreetInsider
Form 8-K CRISPR Therapeutics AG For: Mar 16
March 16, 2026 4:07 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: Mar 10 Filed by: Kulkarni Samarth
March 12, 2026 5:35 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: Mar 10 Filed by: KASINGER JAMES R.
March 12, 2026 5:35 PM - SEC Filing
Form 8-K CRISPR Therapeutics AG For: Mar 10
March 11, 2026 7:08 AM - SEC Filing
CRISPR Therapeutics prices $550 million convertible notes offering
March 11, 2026 7:00 AM - StreetInsider
CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering
March 11, 2026 7:00 AM - Globe NewsWire
CRISPR Therapeutics announces $350 million convertible notes offering
March 10, 2026 7:01 AM - StreetInsider
CRISPR Therapeutics Announces Proposed Convertible Senior Notes Offering
March 10, 2026 7:01 AM - Globe NewsWire
Full Article List
